Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Medical Care Facilities

Global Health Limited engages in the provision of healthcare services in India. The company primarily offers treatments in the areas of digestive and hepatobiliary sciences, cardiac and cancer care, neurosciences, gastrosciences, musculoskeletal disorders and orthopaedics, renal care, liver transplant, lung transplant, bone marrow transplant, chest surgery, gynaecology and gynaeoncology, paediatric care, obstetrics, plastic, aesthetic and reconstructive surgery, ENT, head and neck surgery, internal medicine, respiratory and sleep medicine, peripheral vascular and endovascular sciences, endocrinology and diabetes, rheumatology and immunology, radiology and imaging, ophthalmology, critical care, dermatology, dentistry, ayurveda, and dietetics and nutrition. It also offers lab tests and diagnostics, homecare and elder care services, telemedicine and air ambulance services, blood bank and e-ICU services, and health plans, as well as operates pharmacies. The company operates a network of hospitals under the Medanta brand. Global Health Limited was incorporated in 2004 and is based in New Delhi, India.

Revenue projections:

Revenue projections for MEDANTA
Revenue projections for MEDANTA

MEDANTA's revenue projections indicate a decrease from last year's performance, which could lead to investor caution. A fall in revenue is likely to negatively impact the company's profitability, causing concern for shareholders who may view this as a signal of declining financial health.

Financial Ratios:

currentRatio 0.000000
forwardPE 46.537766
debtToEquity 21.188000
earningsGrowth 0.492000
revenueGrowth 0.197000
grossMargins 0.536620
operatingMargins 0.176440
trailingEps 19.880000
forwardEps 23.410000

Global Health Limited's low Debt-to-Equity ratio indicates the company is not over-leveraged. By limiting its dependence on debt, Global Health Limited reduces its financial risk and demonstrates a strong capital structure, making it a more stable investment option for those wary of excessive borrowing.
Global Health Limited's positive earnings and revenue growth point to business expansion on the horizon. The company is positioned for continued success, with increasing profits and revenue growth highlighting a strong path forward for future growth.
MEDANTA's forward EPS exceeding its trailing EPS means the company is expected to be more profitable this year than last. This suggests an upward trend in earnings, with forecasts indicating that MEDANTA's financial performance will improve in the current financial year.

Price projections:

Price projections for MEDANTA
Price projections for MEDANTA

MEDANTA's price projections have been revised upward over time, suggesting that analysts are becoming more confident in the company's future. This trend points to increased optimism about MEDANTA's ability to grow.

Recommendation changes over time:

Recommendations trend for MEDANTA
Recommendations trend for MEDANTA


A recent buy bias from analysts toward MEDANTA indicates strong confidence in the stock's future performance. This could encourage investors to park their money in MEDANTA, viewing it as a stable and potentially rewarding investment opportunity with promising long-term growth prospects.